Immunomedics | iPharmaCenter

top of page

iPharmaCenter

Global | Comprehensive | Patient Centric

Home
COVID-19
News
Conferences
Healthcare Policies
Regional News
Patient info
Contact
More

Use tab to navigate through the menu items.

All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam

Search

To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired

ipharmaservices

Sep 18, 2020

To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired

For sponsored articles and advertisements, please write to ipharmaservices@gmail.com

Healthcare Policies

©2022 by ipharmaservices

iPharmaCenter

bottom of page